Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Poultry Science
|
June 30, 2016
Discovery of an expanded set of avian leukosis subgroup E proviruses in chickens using Vermillion, a novel sequence capture and analysis pipeline [corrected]
K Rutherford, C J Meehan, M G I Langille, et al.
Poultry Science
|
October 22, 2016
Discovery of an expanded set of avian leucosis subgroup E proviruses in chickens using Vermillion, a novel sequence capture and analysis pipeline
K Rutherford, C J Meehan, M G I Langille, et al.
Environmental Management
|
July 11, 2025
Climate Consideration in Environmental Effects Analyses on Federal Public Lands in the United States
Sarah E Whipple, Sarah K Carter, Tait K Rutherford, et al.
Animal : an International Journal of Animal Bioscience
|
November 12, 2015
Review: Assessment of completeness of reporting in intervention studies using livestock: an example from pain mitigation interventions in neonatal piglets
A O'Connor, R Anthony, L Bergamasco, et al.
Animal Health Research Reviews
|
January 22, 2015
Pain management in the neonatal piglet during routine management procedures. Part 2: grading the quality of evidence and the strength of recommendations
A O'Connor, R Anthony, L Bergamasco, et al.
The Lancet. Oncology
|
December 3, 2023
Overall survival with [<sup>177</sup>Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Michael S Hofman, Louise Emmett, Shahneen Sandhu, et al.
Nature
|
October 5, 2001
Genome sequence of Yersinia pestis, the causative agent of plague
J Parkhill, B W Wren, N R Thomson, et al.
Lancet (London, England)
|
February 14, 2021
[<sup>177</sup>Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S Hofman, Louise Emmett, Shahneen Sandhu, et al.
The Lancet. Oncology
|
February 16, 2025
Overall survival and quality of life with [<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
Louise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
The Lancet. Oncology
|
April 15, 2024
[<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Louise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Poultry Science
|
June 30, 2016
Discovery of an expanded set of avian leukosis subgroup E proviruses in chickens using Vermillion, a novel sequence capture and analysis pipeline [corrected]
K Rutherford, C J Meehan, M G I Langille, et al.
Poultry Science
|
October 22, 2016
Discovery of an expanded set of avian leucosis subgroup E proviruses in chickens using Vermillion, a novel sequence capture and analysis pipeline
K Rutherford, C J Meehan, M G I Langille, et al.
Environmental Management
|
July 11, 2025
Climate Consideration in Environmental Effects Analyses on Federal Public Lands in the United States
Sarah E Whipple, Sarah K Carter, Tait K Rutherford, et al.
Animal : an International Journal of Animal Bioscience
|
November 12, 2015
Review: Assessment of completeness of reporting in intervention studies using livestock: an example from pain mitigation interventions in neonatal piglets
A O'Connor, R Anthony, L Bergamasco, et al.
Animal Health Research Reviews
|
January 22, 2015
Pain management in the neonatal piglet during routine management procedures. Part 2: grading the quality of evidence and the strength of recommendations
A O'Connor, R Anthony, L Bergamasco, et al.
The Lancet. Oncology
|
December 3, 2023
Overall survival with [<sup>177</sup>Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Michael S Hofman, Louise Emmett, Shahneen Sandhu, et al.
Nature
|
October 5, 2001
Genome sequence of Yersinia pestis, the causative agent of plague
J Parkhill, B W Wren, N R Thomson, et al.
Lancet (London, England)
|
February 14, 2021
[<sup>177</sup>Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S Hofman, Louise Emmett, Shahneen Sandhu, et al.
The Lancet. Oncology
|
February 16, 2025
Overall survival and quality of life with [<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
Louise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
The Lancet. Oncology
|
April 15, 2024
[<sup>177</sup>Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Louise Emmett, Shalini Subramaniam, Megan Crumbaker, et al.
Page
of 3